Loss Per Share Applicable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to ChromaDex Corporation	$ (492)	$ (1,902)
Basic loss per common share (in dollars per share)	$ (0.01)	$ (0.03)
Diluted loss per common share (in dollars per share)	$ (0.01)	$ (0.03)
Basic weighted average common shares outstanding (in shares)	75,230	74,796
Diluted weighted average common shares outstanding (in shares)	75,230	74,796
Potentially dilutive securities:
Restricted stock units (in shares)	894	945
Nonvested shares of restricted stock (in shares)	167	183
Stock options
Potentially dilutive securities:
Stock options (in shares)	13,845	12,513